Delivery Order 36F79720D0237-36C24824N0502
Award Date
3/1/24
Potential Completion Date
9/30/24
Potential Value
$90K
Federal Agency
Veterans Integrated Service Network 8
Ultimate Awardee
Bayer AG
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Whippany, Hanover, NJ 07981, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit pharmaceutical company. The order is for the supply of Xofigo (radium Ra 223 dichloride) injections, a prostate cancer treatment, to VA facilities. The award has a potential value of $292,836.43 and covers the period from November 1, 2019 to October 31, 2020. The contract was made under the VA's...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of Xofigo (radium Ra-223 dichloride injection), a radiopharmaceutical treatment for prostate cancer, with an individual dose of 166.14 microcuries to be administered about every 4 weeks up to a total of 6 doses. The contract has a ceiling value of $75,105.29 and is a firm-fixed-price...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit organization. The contract is for the supply of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical product used for the treatment of prostate cancer. The contract has a ceiling value of $670,000.00 and a period of performance from October 1, 2016, to September 30, 2017. The contract was awarded under the VA's...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit company, for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract, with a ceiling value of $302,784.30, is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award has no set-aside designation, and the place...
This is a $131,180 firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the RA-223 (Xofigo) treatment for cancer patients, which is a specialized radiopharmaceutical product. The award is under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows various federal agencies to place delivery orders for a broad range of...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) used for the treatment of prostate cancer. The contract has a ceiling value of $385,706.06 and a period of...
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, under the VA's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The $148,746.00 Firm Fixed Price contract is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) used to treat prostate cancer. This delivery order does not have a set-aside designation. Bayer Healthcare...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization, for the delivery of Xofigo (radium Ra 223 dichloride) injection, a radiopharmaceutical product used for the treatment of prostate cancer. The contract, valued at $75,087.37, was awarded by the Department of Veterans Affairs (VA) under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract is a delivery order, with a firm fixed price...
This federal contract award is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) to the Department of Veterans Affairs (VA) and other federal agencies. The contract, valued at $510,000.00, was awarded to the prime contractor Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is a Delivery Order placed under Bayer's existing $840 million multiple award Federal Supply Schedule contract with the VA for...